Objectives To evaluate whether type 2 diabetes mellitus (T2DM) presence and severity are associated with differences in global and domain-specific cognitive function among US adults, using ...
Blue Cross Blue Shield of Massachusetts had one of its worst financial results in its history in 2025, underscoring the turbulence and disruption caused by ever-rising health care costs. The state’s ...
ABSTRACT: Treatment-Resistant Depression (TRD) remains one of the most challenging subtypes of major depressive disorder, affecting approximately one-third of patients and leading to significant ...
Binary cross-entropy (BCE) is the default loss function for binary classification—but it breaks down badly on imbalanced datasets. The reason is subtle but important: BCE weighs mistakes from both ...
Taobao and Tmall, Alibaba‘s core e-commerce business, is joining forces with China‘s popular social commerce platform Xiaohongshu, or Rednote, in an effort to boost online sales amid a structural ...
ABSTRACT: Accurate histological classification of lung cancer in CT images is essential for diagnosis and treatment planning. In this study, we propose a vision transformer (ViT) model with two-stage ...
Blue Cross Blue Shield of Massachusetts says it will soon stop covering popular drugs for weight loss, like Ozempic and Wegovy. The medications have skyrocketed in price and popularity, but they're ...
The state’s largest commercial health insurer will stop covering a popular class of prescription drugs for weight loss, effective Jan. 1, citing soaring costs that are overwhelming insurers and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results